Alison L. Laidley

TL;DR: Dermal injection of radioactive colloid significantly improves the SLN identification rate compared with peritumoral or subdermal injection, and the false-negative rate is also minimized by the use of dermal injection.

TL;DR: Surgeons should perform at least 20 SLN cases with acceptable results before abandoning routine axillary dissection, and this study provides a model for surgeon training and experience that may be applicable to the implementation of other new surgical technologies.

TL;DR: There were no statistically significant differences in SLN identification rate or false-negative rate between patients undergoing excisional versus needle biopsy, nor does the type of definitive surgical procedure affect the accuracy of SLN biopsy.

TL;DR: The impact of patient and physician factors on surgical decision‐making in breast conservation surgery and mastectomy is evaluated.

TL;DR: Optimal SLN biopsy technique using an intradermal and/or subareolar injection of radioactive colloid and blue dye can improve sentinel lymph node identification rates regardless of patient and tumor characteristics.